This personalized medicine approach could make the difference between success and failure for individual patients
Preliminary mechanistic investigations suggest that GLP-1 medicines exert direct anti-inflammatory effects, reducing biomarkers such as C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-)
Also, a recent systematic review indicates that tirzepatide treatment in adults is associated with reductions in fat mass, relative preservation of lean mass, and decreases in MFI [69], all of which are critical for sarcopenia risk and functional capacity
A 2025 Consumer Reports survey found 34% of GLP-1 patients hit unexpected charges, and this is where most of them came from
The fix is to heal the barrier first
Download the NHS App To access your medical records To manage your prescriptions To message your practice For information on how to stay safe on-line CLICK HERE Weight Loss Injection/ GLP-1 What Are GLP-1 Medicines